Todd Harris, MD
Vascular & Interventional Radiology · Newport Beach, CANPI 1710980677
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 62.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $13,810 and has fallen 99.6% since, to $49 in 2025.
Across 34 payments — averaging $761.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Covidien LP$6K
- Davol Inc.$2K
- Johnson & Johnson$1K
- Bard Access Systems, Inc.$300
- Organogenesis Inc.$101
- plus $64 from 2 others
What the payments were for
- Consulting fees$9,11535%
- Speaking & faculty fees$15,15058%
- Travel & lodging$2511%
- Food & beverage$1,3925%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $16,266 |
| Covidien LP | 8 | $5,679 |
| Davol Inc. | 4 | $2,410 |
| Johnson & Johnson | 2 | $1,087 |
| Bard Access Systems, Inc. | 1 | $300 |
| Organogenesis Inc. | 1 | $101 |
| Terumo Medical Corporation | 2 | $50 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProGrip$5,479
- Dextile$2,669
- STRATAFIX$1,065
- AbsorbaTack$143
- PuraPly$101
How this compares
$25,907 in reported general payments places this provider in the 80th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Newport Beach
- Alexander MisonoNewport Beach$1.3M
- Trushar PatelNewport Beach$124K
- Christopher BakerNewport Beach$116K
- Mahmood RazaviOrange$2.4M
- Keith TerasakiLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Edward LeeLos Angeles$1.4M
- Kevin BurnsOrange$1.1M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.